BMS-P5 free base is a specific and orally active peptidylarginine deiminase 4 (PAD4) inhibitor that blocks the formation of Neutrophil Extracellular Traps and delays the progression of multiple myeloma. Administration of BMS-P5 to multiple myeloma-bearing mice delays symptom onset and disease progression. Targeting PAD4 may be beneficial for treating multiple myeloma.
Molecular Weight:
472.58
Purity:
99.96%
CAS Number:
[1550371-22-6]
Formula:
C27H32N6O2
Target:
PAD
T22277L
* VAT and and shipping costs not included. Errors and price changes excepted
